clinical trial · NCT04652882
Evaluating the Effects of Tasimelteon vs. Placebo in Delayed Sleep-Wake Phase Disorder (DSWPD)
Sleep Wake DisordersSleep Disorders, Circadian RhythmChronobiology DisordersTasimelteonPlacebo
brief summary
This is a multicenter, double-blind, randomized study to evaluate the efficacy and safety of a daily single oral dose of tasimelteon and matching placebo in male and female participants with DSWPD.
started
Dec 9, 2020
primary completion
Jun 1, 2026
completion
Jun 1, 2026
last updated
Dec 2, 2025
official title
A Multicenter, Double-blind, Randomized Study to Evaluate the Effects of Tasimelteon vs. Placebo in Participants With Delayed Sleep-Wake Phase Disorder (DSWPD)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol